Related references
Note: Only part of the references are listed.A largely random AAV integration profile after LPLD gene therapy
Christine Kaeppel et al.
NATURE MEDICINE (2013)
The identity of the cell adhesive protein substrate affects the efficiency of adeno-associated virus reverse transduction
Kellie I. McConnell et al.
ACTA BIOMATERIALIA (2012)
Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma
E. Antonio Chiocca et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
An Evolved Adeno-associated Viral Variant Enhances Gene Delivery and Gene Targeting in Neural Stem Cells
Jae-Hyung Jang et al.
MOLECULAR THERAPY (2011)
Release of Bioactive Adeno-Associated Virus from Fibrin Scaffolds: Effects of Fibrin Glue Concentrations
Hannah H. Lee et al.
TISSUE ENGINEERING PART A (2011)
Fibrin scaffold promotes adenoviral gene transfer and controlled vector delivery
Ailish Breen et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2009)
Adeno-associated virus vector Genomes persist as episomal chromatin in primate muscle
Magalie Penaud-Budloo et al.
JOURNAL OF VIROLOGY (2008)
Effect of gene therapy on visual function in Leber's congenital amaurosis
James W. B. Bainbridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Becaplermin gel in the treatment of diabetic neuropathic foot ulcers
Nikolaos Papanas et al.
CLINICAL INTERVENTIONS IN AGING (2008)
Designer gene delivery vectors: Molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer
Inchan Kwon et al.
PHARMACEUTICAL RESEARCH (2008)
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G. Kaplitt et al.
LANCET (2007)
Perivenous application of fibrin glue as external support enhanced adventitial adenovirus transfection in rabbit model
Li Wan et al.
JOURNAL OF SURGICAL RESEARCH (2006)
Optimization of a fibrin scaffold for sustained release of an adenoviral gene vector
Ailish Breen et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2006)
Adeno-associated virus (AAV)-7 and-8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation
L Denby et al.
GENE THERAPY (2005)
Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors
SJ White et al.
CIRCULATION (2004)
Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy
RM Schek et al.
MOLECULAR THERAPY (2004)
Progress in the use of adeno-associated viral vectors for gene therapy
H Buning et al.
CELLS TISSUES ORGANS (2004)
Robust adenoviral and adeno-associated viral gene transfer to the in vivo murine heart - Application to study of phospholamban physiology
HC Champion et al.
CIRCULATION (2003)
Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics
MP Lutolf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse
M Galeano et al.
DIABETOLOGIA (2003)
Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells
K Pajusola et al.
JOURNAL OF VIROLOGY (2002)
Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR
UP Rohr et al.
JOURNAL OF VIROLOGICAL METHODS (2002)
Effect of well defined dodecahedral porosity on inflammation and angiogenesis
D Bezuidenhout et al.
ASAIO JOURNAL (2002)
Recombinant AAV vector encoding human VEGF165 enhances wound healing
B Deodato et al.
GENE THERAPY (2002)
Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells
SA Nicklin et al.
MOLECULAR THERAPY (2001)
Covalently conjugated VEGF-fibrin matrices for endothelialization
AH Zisch et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors
J Doukas et al.
HUMAN GENE THERAPY (2001)
Sustained effects of gene-activated matrices after CNS injury
M Berry et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2001)
Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column
A Auricchio et al.
HUMAN GENE THERAPY (2001)
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
MA Kay et al.
NATURE MEDICINE (2001)
FGF2-targeted adenovirus encoding platelet-derived growth factor-B enhances de Novo tissue formation
LA Chandler et al.
MOLECULAR THERAPY (2000)
Development of fibrin derivatives for controlled release of heparin-binding growth factors
SE Sakiyama-Elbert et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
MA Kay et al.
NATURE GENETICS (2000)
Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts
J Hansen et al.
JOURNAL OF VIROLOGY (2000)
AAV vectors: is clinical success on the horizon?
PE Monahan et al.
GENE THERAPY (2000)
Share Paper
